Literature DB >> 15496293

Locus coeruleus activity in perinatally protein-deprived rats: effects of fluoxetine administration.

Alejandro O Sodero1, Analía Valdomero, Gabriel R Cuadra, Oscar A Ramírez, Otto A Orsingher.   

Abstract

We have previously described an increased locus coeruleus activity in perinatally protein-deprived rats. Since locus coeruleus dysfunction has been involved in different types of anxiety disorders and considering the modulating action of serotonergic transmission on locus coeruleus activity, we assessed the effect of fluoxetine, a selective serotonin reuptake inhibitor (SSRI), on locus coeruleus activity as measured by the firing rate and the number of spontaneously active cells/track. Repeated fluoxetine administration reduced locus coeruleus activity in both control and protein-deprived rats, although the reduction was greater in protein-deprived rats. Dose-response curves for the inhibitory effect of clonidine showed subsensitivity of alpha2-adrenergic autoreceptors in protein-deprived rats, a phenomenon reversed by fluoxetine treatment. Dose-response curves for the inhibitory effect of 2,5-dimethoxy-4-iodoamphetamine (DOI) were similar in both groups of rats. Following fluoxetine administration, subsensitivity to this effect developed in control but not in protein-deprived rats. Extracellular noradrenaline level in the prefrontal cortex, as measured by microdialysis procedure, was higher in protein-deprived rats compared to controls, and this difference was reduced after fluoxetine administration. A challenge with yohimbine increased the extracellular noradrenaline level in control but not in protein-deprived rats, suggesting subsensitivity of alpha2-adrenergic autoreceptors in early protein malnourished animals. These results stress the complexity of plastic changes induced by early protein malnutrition and sustain the hypothesis that perinatally protein-deprived rats may represent a useful animal model for screening antipanic agents.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15496293     DOI: 10.1016/j.ejphar.2004.09.007

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Olanzapine and fluoxetine combination therapy for treatment-resistant depression: review of efficacy, safety, and study design issues.

Authors:  William V Bobo; Richard C Shelton
Journal:  Neuropsychiatr Dis Treat       Date:  2009-07-02       Impact factor: 2.570

2.  Long-term administration of citalopram reduces basal and stress-induced extracellular noradrenaline levels in rat brain.

Authors:  Yukie Kawahara; Hiroshi Kawahara; Fumi Kaneko; Masatoshi Tanaka
Journal:  Psychopharmacology (Berl)       Date:  2007-05-30       Impact factor: 4.530

Review 3.  In vivo electrophysiological recordings of the effects of antidepressant drugs.

Authors:  Paul J Fitzgerald; Brendon O Watson
Journal:  Exp Brain Res       Date:  2019-05-11       Impact factor: 1.972

Review 4.  The Role of the Paraventricular-Coerulear Network on the Programming of Hypertension by Prenatal Undernutrition.

Authors:  Bernardita Cayupe; Blanca Troncoso; Carlos Morgan; Patricio Sáez-Briones; Ramón Sotomayor-Zárate; Luis Constandil; Alejandro Hernández; Eugenia Morselli; Rafael Barra
Journal:  Int J Mol Sci       Date:  2022-10-08       Impact factor: 6.208

Review 5.  The role of the locus coeruleus in the generation of pathological anxiety.

Authors:  Laurel S Morris; Jordan G McCall; Dennis S Charney; James W Murrough
Journal:  Brain Neurosci Adv       Date:  2020-07-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.